These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26612219)

  • 1. Diagnosis of Renal Cell Carcinoma: A Clinician's Perspective.
    Albiges L; Fay AP; McKay RR; Kaymakcalan MD; Choueiri TK
    Surg Pathol Clin; 2015 Dec; 8(4):657-62. PubMed ID: 26612219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ancillary diagnostic techniques in the evaluation of adult epithelial renal neoplasms: indications, caveats, and pitfalls.
    Herrera GA; Turbat-Herrera EA
    Appl Immunohistochem Mol Morphol; 2014; 22(2):77-98. PubMed ID: 24162266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal cell carcinoma and mimics: pathologic primer for radiologists.
    Bai X; Wu CL
    AJR Am J Roentgenol; 2012 Jun; 198(6):1289-93. PubMed ID: 22623540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic models and algorithms in renal cell carcinoma.
    Lane BR; Kattan MW
    Urol Clin North Am; 2008 Nov; 35(4):613-25; vii. PubMed ID: 18992615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Entities in Renal Neoplasia.
    Mehra R; Smith SC; Divatia M; Amin MB
    Surg Pathol Clin; 2015 Dec; 8(4):623-56. PubMed ID: 26612218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current trends in the molecular classification of renal neoplasms.
    Young AN; Master VA; Amin MB
    ScientificWorldJournal; 2006 Dec; 6():2505-18. PubMed ID: 17619725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
    Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
    Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic and prognostic markers of renal cell carcinoma].
    Spadaccino F; Netti GS; Rocchetti MT; Castellano G; Stallone G; Ranieri E
    G Ital Nefrol; 2020 Apr; 37(2):. PubMed ID: 32281759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of renal cell carcinoma in children: a report from the Polish pediatric rare tumor study group.
    Stachowicz-Stencel T; Bien E; Balcerska A; Godzinski J; Synakiewicz A; Perek-Polnik M; Kurylak A; Pietras W; Kuzmicz M; Mizia-Malarz A; Rybczynska A; Nurzynska-Flak J
    Klin Padiatr; 2011 May; 223(3):138-41. PubMed ID: 21509711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal cell carcinoma--diagnosis, differential diagnosis and prognosis].
    Liedl B; Liedl T; Hofstetter AG
    Fortschr Med; 1992 Aug; 110(24):431-4. PubMed ID: 1398388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of leptin as a biomarker for early detection of renal cell carcinoma? No evidence from a systematic review and meta-analysis.
    Perumal K; Huin WK; Yap NY; Ong TA; Gobe GC; Rajandram R
    Med Hypotheses; 2019 Aug; 129():109239. PubMed ID: 31371068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multilocular cystic renal cell carcinoma: comparison of imaging and pathologic findings.
    Hindman NM; Bosniak MA; Rosenkrantz AB; Lee-Felker S; Melamed J
    AJR Am J Roentgenol; 2012 Jan; 198(1):W20-6. PubMed ID: 22194510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genitourinary imaging: part 2, role of imaging in medical management of advanced renal cell carcinoma.
    Shinagare AB; Krajewski KM; Jagannathan JP; Ramaiya NH
    AJR Am J Roentgenol; 2012 Nov; 199(5):W554-64. PubMed ID: 23096199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD70: a new tumor specific biomarker for renal cell carcinoma.
    Junker K; Hindermann W; von Eggeling F; Diegmann J; Haessler K; Schubert J
    J Urol; 2005 Jun; 173(6):2150-3. PubMed ID: 15879877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma in children: a rare entity.
    Gilani JA; Iqbal M; Khattak MR; Shahid S
    J Ayub Med Coll Abbottabad; 2011; 23(2):184-5. PubMed ID: 24800377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
    Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
    Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic computed tomography and Doppler findings in different subtypes of renal cell carcinoma with their histopathological correlation.
    Sureka B; Lal A; Khandelwal N; Joshi K; Singh SK; Agarwal MM; Mittal A
    J Cancer Res Ther; 2014; 10(3):552-7. PubMed ID: 25313738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.
    Jhaveri KS; Elmi A; Hosseini-Nik H; Hedgire S; Evans A; Jewett M; Harisinghani M
    AJR Am J Roentgenol; 2015 Jul; 205(1):W79-86. PubMed ID: 26102422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncocytic renal neoplasms: diagnostic considerations.
    Abrahams NA; Tamboli P
    Clin Lab Med; 2005 Jun; 25(2):317-39, vi. PubMed ID: 15848739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant and neoadjuvant therapies in high-risk renal cell carcinoma.
    Smaldone MC; Fung C; Uzzo RG; Haas NB
    Hematol Oncol Clin North Am; 2011 Aug; 25(4):765-91. PubMed ID: 21763967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.